Christopher Zappala

2.0k total citations
28 papers, 1.1k citations indexed

About

Christopher Zappala is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Christopher Zappala has authored 28 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 9 papers in Physiology and 5 papers in Epidemiology. Recurrent topics in Christopher Zappala's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (20 papers), Sarcoidosis and Beryllium Toxicity Research (9 papers) and Occupational and environmental lung diseases (7 papers). Christopher Zappala is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (20 papers), Sarcoidosis and Beryllium Toxicity Research (9 papers) and Occupational and environmental lung diseases (7 papers). Christopher Zappala collaborates with scholars based in Australia, United Kingdom and United States. Christopher Zappala's co-authors include Athol U. Wells, Elisabetta Renzoni, David M. Hansell, Andrew G. Nicholson, Thomas V. Colby, D. Cramer, R M du Bois, P. Latsi, Toby M. Maher and Sacha Macansh and has published in prestigious journals such as CHEST Journal, European Respiratory Journal and Quality of Life Research.

In The Last Decade

Christopher Zappala

26 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Zappala Australia 13 1.0k 436 273 189 126 28 1.1k
Angelo Carloni Italy 15 706 0.7× 296 0.7× 49 0.2× 98 0.5× 67 0.5× 25 904
José Valverde Spain 12 388 0.4× 222 0.5× 42 0.2× 96 0.5× 309 2.5× 32 673
Sara Kashef Iran 13 126 0.1× 146 0.3× 93 0.3× 77 0.4× 70 0.6× 44 570
Elizabeth A. Belloli United States 11 577 0.6× 192 0.4× 36 0.1× 94 0.5× 38 0.3× 25 663
Rosamaria Mura Italy 13 84 0.1× 93 0.2× 99 0.4× 126 0.7× 30 0.2× 40 571
Stavros Anevlavis Greece 16 496 0.5× 129 0.3× 22 0.1× 134 0.7× 22 0.2× 46 702
Kazunori Tobino Japan 14 514 0.5× 269 0.6× 17 0.1× 61 0.3× 36 0.3× 82 744
Anne M. Goff United States 8 574 0.6× 232 0.5× 30 0.1× 77 0.4× 223 1.8× 14 684
Takaaki Ogoshi Japan 11 218 0.2× 90 0.2× 34 0.1× 90 0.5× 36 0.3× 25 362
A. K. Purohit India 15 109 0.1× 36 0.1× 57 0.2× 182 1.0× 66 0.5× 36 639

Countries citing papers authored by Christopher Zappala

Since Specialization
Citations

This map shows the geographic impact of Christopher Zappala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Zappala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Zappala more than expected).

Fields of papers citing papers by Christopher Zappala

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Zappala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Zappala. The network helps show where Christopher Zappala may publish in the future.

Co-authorship network of co-authors of Christopher Zappala

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Zappala. A scholar is included among the top collaborators of Christopher Zappala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Zappala. Christopher Zappala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mackintosh, John A., Marc Sylva, Lucio Calandriello, et al.. (2026). Likelihood of Usual Interstitial Pneumonia: A Novel Approach to Prognosis for Pulmonary Fibrosis. Respirology.
2.
Tan, Dino B.A., Wendy A. Cooper, Helen E. Jo, et al.. (2025). Pre‐Treatment MMP7 Predicts Progressive Idiopathic Pulmonary Fibrosis in Antifibrotic Treated Patients. Respirology. 30(6). 504–514. 2 indexed citations
3.
Yang, Nan, Francesco Federico, Stephen M. Humphries, et al.. (2025). Prognostication in patients with idiopathic pulmonary fibrosis using quantitative airway analysis from HRCT: a retrospective study. European Respiratory Journal. 66(4). 2500981–2500981.
4.
Tozer, Sarah, Kimberly B. Ulett, David L. Paterson, et al.. (2024). Comparing Polymerase Chain Reaction Testing of Nasopharyngeal Swab and Lower Respiratory Tract Specimens for the Diagnosis of Pneumocystis jirovecii Pneumonia. Open Forum Infectious Diseases. 11(3). ofae071–ofae071. 1 indexed citations
5.
6.
Boots, Robert, Oliver Rawashdeh, Judith Bellapart, et al.. (2021). Temperature rhythms and ICU sleep: the TRIS study. Minerva Anestesiologica. 87(7). 794–802. 2 indexed citations
7.
8.
Bellapart, Judith, et al.. (2020). Effect of Exogenous Melatonin Administration in Critically Ill Patients on Delirium and Sleep: A Randomized Controlled Trial. Critical Care Research and Practice. 2020. 1–9. 12 indexed citations
9.
Jo, Helen E., Tamera J. Corte, Ian Glaspole, et al.. (2019). Gastroesophageal reflux and antacid therapy in IPF: analysis from the Australia IPF Registry. BMC Pulmonary Medicine. 19(1). 84–84. 22 indexed citations
10.
Brannan, John D., John Attia, Kerrin Palazzi, et al.. (2019). Eligibility for anti‐fibrotic treatment in idiopathic pulmonary fibrosis depends on the predictive equation used for pulmonary function testing. Respirology. 24(10). 988–995. 5 indexed citations
11.
Jo, Helen E., Ian Glaspole, Yuben Moodley, et al.. (2018). Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registry. BMC Pulmonary Medicine. 18(1). 19–19. 55 indexed citations
12.
Jo, Helen E., Ian Glaspole, Christopher Grainge, et al.. (2017). Baseline characteristics of idiopathic pulmonary fibrosis: analysis from the Australian Idiopathic Pulmonary Fibrosis Registry. European Respiratory Journal. 49(2). 1601592–1601592. 161 indexed citations
13.
Schmidt, Shelley L., Nabihah Tayob, MeiLan K. Han, et al.. (2013). Predicting Pulmonary Fibrosis Disease Course From Past Trends in Pulmonary Function. CHEST Journal. 145(3). 579–585. 77 indexed citations
14.
Lauretis, Angelo De, Piersante Sestini, Christopher Zappala, et al.. (2013). Serum Interleukin 6 Is Predictive of Early Functional Decline and Mortality in Interstitial Lung Disease Associated with Systemic Sclerosis. The Journal of Rheumatology. 40(4). 435–446. 190 indexed citations
15.
Zappala, Christopher, Sujal R. Desai, Susan J. Copley, et al.. (2013). Accuracy of Individual Variables in the Monitoring of Long-term Change in Pulmonary Sarcoidosis as Judged by Serial High-Resolution CT Scan Data. CHEST Journal. 145(1). 101–107. 33 indexed citations
16.
Zappala, Christopher, Sujal R. Desai, Susan J. Copley, et al.. (2011). Optimal scoring of serial change on chest radiography in sarcoidosis.. PubMed. 28(2). 130–8. 34 indexed citations
17.
Corte, Tamera J., Susan J. Copley, Sujal R. Desai, et al.. (2011). Significance of connective tissue disease features in idiopathic interstitial pneumonia. European Respiratory Journal. 39(3). 661–668. 132 indexed citations
18.
Zappala, Christopher, P. Latsi, Andrew G. Nicholson, et al.. (2009). Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis. European Respiratory Journal. 35(4). 830–836. 259 indexed citations
19.
Zappala, Christopher, et al.. (2007). The antimicrobial effect of heparin on common respiratory pathogens. Critical Care and Resuscitation. 9(2). 157–160. 9 indexed citations
20.
Cacopardo, Bruno, Luca Lo Nigro, Simona Tosto, et al.. (1992). Eosinophilic ileocolitis by Enterobius vermicularis: a description of two rare cases.. Información Comercial Española, ICE: Revista de economía. 29(1). 16–24. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Angelo Carloni Breakdown of academic impact, for papers by José Valverde Breakdown of academic impact, for papers by Sara Kashef Breakdown of academic impact, for papers by Elizabeth A. Belloli Breakdown of academic impact, for papers by Rosamaria Mura Breakdown of academic impact, for papers by Stavros Anevlavis Breakdown of academic impact, for papers by Kazunori Tobino Breakdown of academic impact, for papers by Anne M. Goff Breakdown of academic impact, for papers by Takaaki Ogoshi Breakdown of academic impact, for papers by A. K. Purohit
Rankless by CCL
2026